Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana K Shirey-Rice

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Disease Models & Mechanisms|April 13, 2013
Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndromeJana K Shirey-Rice, Rebecca Klar, Hugh M Fentress, et al.
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study protocol and statistical analysis plan for a randomized controlled trial evaluating the safety and feasibility of the recombinant human platelet-derived growth factor B (rhPDGF-BB)-enhanced collagen plug for complex perianal fistula healingMarissa C Kuo, Samuel A Younan, Melissa D Lempicki, et al.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Study protocol and statistical analysis plan for a randomized, double-blind, controlled trial evaluating recombinant human platelet-derived growth factor B (rhPDGF) in the reconstruction of complex head or neck defects following skin cancer excisionCyndi R Clark, Bryan S Blette, Ricardo A Torres Guzman, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Bioinformatics (Oxford, England)|December 6, 2022
Interactive network-based clustering and investigation of multimorbidity association matrices with associationSubgraphsNick Strayer, Siwei Zhang, Lydia Yao, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Disease Models & Mechanisms|April 13, 2013
Norepinephrine transporter variant A457P knock-in mice display key features of human postural orthostatic tachycardia syndromeJana K Shirey-Rice, Rebecca Klar, Hugh M Fentress, et al.
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study protocol and statistical analysis plan for a randomized controlled trial evaluating the safety and feasibility of the recombinant human platelet-derived growth factor B (rhPDGF-BB)-enhanced collagen plug for complex perianal fistula healingMarissa C Kuo, Samuel A Younan, Melissa D Lempicki, et al.
Targeted Oncology|December 9, 2017
Motivation for Launching a Cancer Metastasis Inhibition (CMI) ProgramJill M Pulley, Rebecca N Jerome, Martin L Ogletree, et al.
Frontiers in Genetics|August 16, 2021
Human and Machine Intelligence Together Drive Drug Repurposing in Rare DiseasesAnup P Challa, Nicole M Zaleski, Rebecca N Jerome, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Study protocol and statistical analysis plan for a randomized, double-blind, controlled trial evaluating recombinant human platelet-derived growth factor B (rhPDGF) in the reconstruction of complex head or neck defects following skin cancer excisionCyndi R Clark, Bryan S Blette, Ricardo A Torres Guzman, et al.
Assay and Drug Development Technologies|December 2, 2017
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy DataJill M Pulley, Rebecca N Jerome, Nicole M Zaleski, et al.
Bioinformatics (Oxford, England)|December 6, 2022
Interactive network-based clustering and investigation of multimorbidity association matrices with associationSubgraphsNick Strayer, Siwei Zhang, Lydia Yao, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Pageof 2